Celularity Inc
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $26.6M | $54.2M | $22.8M | $18.0M | $21.3M |
| Gross profit | — | — | $6.8M | -$1.7M | $11.7M |
| Operating income | -$61.3M | -$38.4M | -$192.3M | -$25.6M | -$109.1M |
| Cost of revenue | $20.1M | $15.0M | $16.0M | — | — |
| Cash from operations | -$13.3M | -$6.4M | -$38.7M | -$137.9M | -$110.1M |
| Capital expenditure | — | $161,000 | $1.0M | $5.2M | $6.2M |
| Free cash flow | — | -$6.6M | -$39.7M | -$143.1M | -$116.3M |
| Share repurchases | — | — | — | $86,000 | — |
| Impairments | $0 | $0 | $112.3M | $3.6M | $0 |
| Total assets | $107.3M | $132.7M | $143.9M | $401.1M | $414.1M |
| Total liabilities | $145.4M | $123.8M | $102.9M | $202.2M | $314.7M |
Shares outstanding 28.3M
Annual filing data through FY ended December 31, 2025; float as of July 4, 2026.